-
Posted by
Two Blokes Jul 20 -
Filed in
Stock
-
1 view
Several women who have reported improvements in symptoms of polycystic ovary syndrome, a common hormonal disorder, after using GLP-1s such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound. Patients and some health experts view GLP-1s as a promising potential option for a condition that lacks a standard treatment and affects millions of women in the U.S.
